Ocular side effects and complications of intravitreal triamcinolone acetonide injection;Nebenwirkungen und komplikationen der intravitrealen triamcinolonacetonid-therapie

Ophthalmologe

Volumn 101, Issue 2, 2004, Pages 121-128

  Jaissle, G B ^a   Szurman, P ^a   Bartz Schmidt, K U ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Complications; Intravitreal injection; Side effects; Triamcinolone acetonide

Indexed keywords

TRIAMCINOLONE ACETONIDE;

CATARACT; CENTRAL RETINA ARTERY OCCLUSION; CONJUNCTIVA DISEASE; CYTOTOXICITY; ENDOPHTHALMITIS; EYE DISEASE; GLAUCOMA; HUMAN; INFLAMMATION; RETINA DETACHMENT; RETINITIS; REVIEW;

EID: 1542315930     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-003-0975-z     Document Type: Review

References (52)

1. Agrawal S, Agrawal J, Prakash T (2003) Conjunctival ulceration following triamcinolone injection. Am J Ophthalmol 136:539-540
2. Bakri SJ, Beer PM (2003) The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers 34:386-390
3. Baudouin C, Chassain C, Caujolle C, Gastaud P (1996) Treatment of cytomegalovirus retinitis in AIDS patients using intravitreal injections of highly concentrated ganciclovir. Ophthalmologica 210:329-335
4. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB, Miller M (2003) Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110:681-686
5. Benz MS, Murray TG, Dubovy SR, Katz RS, Eifrig CW (2003) Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol 121:271-273
6. Bouzas EA, Scott MH, Mastorakos G, Chrousos GP, Kaiser-Kupfer MI (1993) Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 111:1229-1233
7. Cantrill HL, Henry K, Melroe NH, Knobloch WH, Ramsay RC, Balfour HH Jr (1989) Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results. Ophthalmology 96:367-374
8. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA (1998) Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol 26:277-281
9. D'Alessandro L, Bottaro E(2002) Reactivation of CMV retinitis after treatment with subtenon corticosteroids for immune recovery uveitis in a patient with AIDS. Scand J Infect Dis 34:780-782
10. Danis RP, Ciulla TA, Pratt LM, Anliker W (2000) Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20:244-250
11. Eifrig CW, Flynn HW Jr, Scott IU, Newton J (2002) Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers 33:373-378
12. Enaida H, Sakamoto T, Ueno A, Nakamura T, Noda Y, Maruoka K, Ishibashi T (2002) Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy. Am J Ophthalmol 13S:243-246
13. Endophthalmitis Vitrectomy Study Group (1995) Results of the endophthalmitis vitrectomy study group. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113:1479-1496
14. Gillies MC, Simpson JM, Luo W et al (2003) A randomized clinical trail of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration. One-year results. Arch Ophthalmol 121:667-673
15. Graham RO, Peyman GA (1974) Intravitreal injection of dexamethasone: treatment of experimentally induced endophthalmitis. Arch Ophthalmol 92:49-S4
16. Haimovici R, Gragoudas ES, Duker JS, Sjaarda RN, Eliott D (1997) Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology 104:1653-1660
17. Harada T, Harada K (1985) Six cases of central serous choroidopathy induced by systemic corticosteroid therapy. Doc Ophthalmol 1S:37-44
18. Hida T, Chandler D, Arena JE, Machemer R (1986) Experimental and clinical observation of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 101:190-195
19. Jonas JB, Kreissig I, Degenring R (2003) Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 87:24-27
20. Jonas JB, Kreissig I, Degenring R (2003) Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol 121:729-730
21. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R (2003) Intravitreal triamcinolone acetonide for exsudative age related macular degeneration. Br J Ophthalmol 87:462-468
22. Kamppeter BA, Jonas JB, Kreissig I, Degenring RF (2003) Endophthalmitis nach intravitrealer Triamcinolon-Injektion. Ophthalmologe 100:169
23. Karsh J, Yang WH (2003) An anaphylactic reaction to intra-articular triamcinolone: a case report and review of the literature. Ann Allergy Asthma Immunol 90:254-258
24. Kim P, Younan N, Coroneo MT (2002) Hypersensitivity reaction to intravitreal clindamycin therapy. Clin Experiment Ophthalmol 30:147-148
25. Kivilcim M, Peyman GA, El-Dessouky ES, Kazi AA, Cheema R, Hegazy H (2000) Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg Lasers 31:474-478
26. Kraushar MF, Nussbaum P, Kisch AL (1994) Anaphylactic reaction to intravitreal cefazolin. Retina 14:187-188
27. Melberg NS, Thomas MA (1995) Nuclear sclerotic cataract after vitrectomy in patients younger than 50 years of age. Ophthalmology 102:1466-1471
28. Modarres M, Parvaresh MM, Peyman GA (1998) Accidental subretinal injection of triamcinolone acetonide. Ophthalmic Surg Lasers 29:935-938
29. Moshfeghi DM, Kaiser PK, Scott IU et al (2003) Acute Endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136:791-796
30. Müller M, Klär-Dilßars U, Hoerauf H, Laqua H (2003) Komplikationen nach intravitrealer Triamcinolon-Acetonid-Injektion. Ophthalmologe 100:192
31. Naumann GOH (1997) Glaukome und Hypotonie-Syndrome (Pathologie des abnormen intraokularen Drucks). In: Naumann GOH (Hrsg) Pathologie des Auges II. Springer, Berlin Heidelberg New York Tokyo, S 1245-1371
32. Nelson ML, Martidis A (2003) Managing cystoid edema after cataract surgery. Curr Opin Ophthalmol 14:39-43
33. Nelson ML, Tennant MTS, Sivalingam A, Regillo CD, Belmont JB, Martidis A (2003) Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23:686-691
34. Park CH, Jaffe GJ, Fekrat S (2003) Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 136:419-425
35. Parke DW (2003) Intravitreal triamcinolone and endophthalmitis. Am J Ophthalmol 136:918-919
36. Patterson DL, Yunginger JW, Dunn WF, Jones RT, Hunt LW (1995) Anaphylaxis induced by the carboxymethylcellulose component of injectable triamcinolone acetonide suspension (Kenalog). Ann Allergy Asthma Immunol 74:163-166
37. Rabinovitch T, Oh JO, Minasi P (1990) In vivo reactivation of latent murine cytomegalovirus in the eye by immunosuppressive treatment. Invest Ophthalmol Vis Sci 31:657-663
38. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA (2003) Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 121:1279-1282
39. Saff DM, Taylor JS, Vidimos AT (1995) Allergic reaction to intralesional triamcinolone acetonide: a case report. Arch Dermatol 131:742-743
40. Sakamoto T, Koga H, Noda Y, Ishibashi T (2002) Optic disk cup filled with triamcinolone. Retina 22:S16-S18
41. Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K, Ishibashi T (2002) Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 240:423-429
42. Salam GA, Moshfeghi AA, Fastenberg DM, Deramo VA, Ferrone PJ (2003) Intravitreal triamcinclone acetonide injection for diabetic macular edema: effect of preparation technique on incidence of anterior chamber reaction. Invest Ophthalmol Vis Sci 44:45S
43. Sandvig KU, Dannevig L (2003) Postoperative endophthalmitis: establishment and results of a national registry. J Cataract Refract Surg 29:1273-1280
44. Schindler RH, Chandler D, Thresher R, Machemer R (1982) The clearance of intravitreal triamcinolone acetonide. Br J Ophthalmol 93:415-417
45. Schlötzer-Schrehardt U, Naumann GOH (1997) Linse. In: Naumann GOH (Hrsg) Pathologie des Auges II. Springer, Berlin Heidelberg New York Tokyo, S 846-954
46. Semmens JB, Li J, Morlet N, Ng J, Team EPSWA (2003) Trends in cataract surgery and postoperative endophthalmitis in Western Australia (1980-1998): the endophthalmitis population study of western australia. Clin Experiment Ophthalmol 31:213-219
47. Shimada H, Matsui M (1989) Effects of intravitreal steroid injection on rabbit eye. Nippon Ganka Gakkai Zasshi 93:S01-S10
48. Sutter FKP, Gillies MC (2003) Interim (3 months) analysis of the safety of intravitreal triamcinolone for diabetic macular edema that persists after laser treatment. Results from a randomized clinical trial: TDMO. Invest Ophthalmol Vis Sci 44:454
49. Sutter FKP, Gillies MC (2003) Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol 87:972-974
50. Wingate RJB, Beaumont PE (1999) Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol 27:431-432
51. Yeung CK, Chan KP, Chiang SWY, Pang CP, Lam DSC (2003) The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci 44:S293-S300
52. Young S, Larkin G, Branley M, Lightman S (2001) Safety and efficacy of intravitreal triamcinolone for cystoid macular edema in uveitis. CIin Exp Ophthalmol 29:2-6